News

Change in Preferred Drug List Status for the Antiemetic-Antivertigo Agents, Drug Class, Effective Jan. 15, 2025

Jan. 2025 NDC-to-HCPCS Crosswalk Now Available for Clinician-Administered Drug Processing

The NDC-to-HCPCS Crosswalk identifies relationships between NDC and Medicaid-reimbursable Healthcare Common Procedure Coding System codes.

"Injectables Not Administered at the Pharmacy" Error Corrected Dec. 22, 2024

Agenda for Jan. 31, 2025, Drug Utilization Review Board Meeting Now Available

Agenda items are now available for the next quarterly meeting of the Texas Drug Utilization Review Board.

VDP Claims, Prior Authorization Systems Maintenance Scheduled For Jan. 19, 2025

Martin Luther King, Jr. Day Holiday to Delay Pharmacy Payments   

Change in PDL Status for the Bronchodilators, Beta Agonist, Drug Class, Effective Jan. 3, 2025

VDP removed the non-preferred status from the generic levalbuterol inhalation solution products on the preferred drug list (PDL) effective Jan. 3, 2025.

Reminder: Pharmacy Contact Information Must Be Current in PEMS

Pharmacy Education Information and Opportunities

Information for pharmacy providers about Medicaid pharmacy benefits.

2025 Pharmacy Enrollment Application Fee Announced

HHSC requires application fees for pharmacies enrolling with Texas Medicaid.